# Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

> **NCT01953107** · PHASE4 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 200 (estimated)

## Conditions studied

- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer
- Anemia

## Interventions

- **OTHER:** Oral Ferrous Fumarate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01953107
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-01
- **Final completion:** 2020-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953107, "Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01953107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*